MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis-related miRNAs (Q37828424)

24 August 2017

1 reference

title

MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis-related miRNAs (English)

1 reference

24 August 2017

1 reference

1 reference

1

Achim Aigner

1 reference

24 August 2017

14 January 2011

1 reference

Journal of Molecular Medicine

24 August 2017

1 reference

24 August 2017

89

1 reference

24 August 2017

445-457

1 reference

24 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1007/s00109-010-0716-0

24 August 2017

0 references

cites work

Metastasis: from dissemination to organ-specific colonization

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Learning therapeutic lessons from metastasis suppressor proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Dissemination and growth of cancer cells in metastatic sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Complex networks orchestrate epithelial-mesenchymal transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Cadherin switch in tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

The role of microRNAs in metastasis and epithelial-mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

The let-7 microRNA represses cell proliferation pathways in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

AngiomiRs--key regulators of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

The nuclear RNase III Drosha initiates microRNA processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Repression of protein synthesis by miRNAs: how many mechanisms?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA function in cancer: oncogene or a tumor suppressor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA signatures in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA expression profiles classify human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Circulating nucleic acids as a potential source for cancer biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Epigenetic regulation of microRNA expression in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNAs as potential cancer therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA-125b is a novel negative regulator of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

The microRNA miR-92 increases proliferation of myeloid cells and by targeting p63 modulates the abundance of its isoforms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Immunofluorescence-based screening identifies germ cell associated microRNA 302 as an antagonist to p63 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

let-7 microRNAs in development, stem cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Epidermal growth factor receptor-regulated miR-125a-5p--a metastatic inhibitor of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Widespread microRNA repression by Myc contributes to tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

miR-21 as a key regulator of oncogenic processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

The role of let-7 in cell differentiation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

miR-15a and miR-16-1 in cancer: discovery, function and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

miR-200 enhances mouse breast cancer cell colonization to form distant metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Stable expression of miR-200c alone is sufficient to regulate TCF8 (ZEB1) and restore E-cadherin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Concurrent suppression of integrin alpha5, radixin, and RhoA phenocopies the effects of miR-31 on metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Concomitant suppression of three target genes can explain the impact of a microRNA on metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

The let-7 microRNA reduces tumor growth in mouse models of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Regression of murine lung tumors by the let-7 microRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Role of anti-oncomirs miR-143 and -145 in human colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Antisense therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Applications of RNA interference: current state and prospects for siRNA-based strategies in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

RNAi therapeutics: a potential new class of pharmaceutical drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

DNAzymes and their therapeutic possibilities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

miR-21-mediated tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

LNA-mediated microRNA silencing in non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Silencing of microRNAs in vivo with 'antagomirs'

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Small-molecule inhibitors of microrna miR-21 function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Stable knockdown of microRNA in vivo by lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Regulation of progenitor cell proliferation and granulocyte function by microRNA-223

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Suppression of non-small cell lung tumor development by the let-7 microRNA family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Recent development of nonviral gene delivery systems with virus-like structures and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Cellular delivery in vivo of siRNA-based therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MiRNA expression in urothelial carcinomas: important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

An inhibitory effect of miR-22 on cell migration and invasion in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MBP-1 upregulates miR-29b that represses Mcl-1, collagens, and matrix-metalloproteinase-2 in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA-125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

miR-126 functions as a tumour suppressor in human gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Endogenous human microRNAs that suppress breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Breast cancer metastasis suppressor 1 coordinately regulates metastasis-associated microRNA expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

miR-146a suppresses invasion of pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA-183 regulates Ezrin expression in lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Dysregulated miR-183 inhibits migration in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

miR-194 is a marker of hepatic epithelial cells and suppresses metastasis of liver cancer cells in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Network modeling identifies molecular functions targeted by miR-204 to suppress head and neck tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

A microRNA expression ratio defining the invasive phenotype in bladder tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

The microRNA-200 family regulates epithelial to mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA-205 inhibits tumor cell migration through down-regulating the expression of the LDL receptor-related protein 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Suppression of cell growth and invasion by miR-205 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA-206 targets notch3, activates apoptosis, and inhibits tumor cell migration and focus formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA-206 is associated with invasion and metastasis of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

The regulation of miRNA-211 expression and its role in melanoma cell invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

miR-10b targets Tiam1: implications for Rac activation and carcinoma migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA-10b induced by Epstein-Barr virus-encoded latent membrane protein-1 promotes the metastasis of human nasopharyngeal carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

The miR200 family of microRNAs regulates WAVE3-dependent cancer cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

EP300--a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA-661, a c/EBPalpha target, inhibits metastatic tumor antigen 1 and regulates its functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA-9 reduces cell invasion and E-cadherin secretion in SK-Hep-1 cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MiR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

SMAD proteins control DROSHA-mediated microRNA maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

BMP-6 inhibits microRNA-21 expression in breast cancer through repressing deltaEF1 and AP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA-21 targets tumor suppressor genes in invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA expression profiles in serous ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Up-regulation of miR-21 by HER2/neu signaling promotes cell invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

ST14 (suppression of tumorigenicity 14) gene is a target for miR-27b, and the inhibitory effect of ST14 on cell growth is independent of miR-27b regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Downregulation of microRNA miR-520h by E1A contributes to anticancer activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

MicroRNA Inhibition of Translation Initiation in Vitro by Targeting the Cap-Binding Complex eIF4F

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0716-0

Drug development against metastasis-related genes and their pathways: A rationale for cancer therapy

21 January 2018

1 reference

12 December 2020

microRNA expression profile in undifferentiated gastric cancer.

1 reference

12 December 2020

MicroRNA-222 regulates cell invasion by targeting matrix metalloproteinase 1 (MMP1) and manganese superoxide dismutase 2 (SOD2) in tongue squamous cell carcinoma cell lines.

1 reference

12 December 2020

MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma

1 reference

12 December 2020

Intracellular and extracellular microRNAs in breast cancer

1 reference

12 December 2020

Mechanisms of metastasis

1 reference

12 December 2020

miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis

1 reference

12 December 2020

Paget's "seed and soil" hypothesis revisited.

1 reference

12 December 2020

miR-145-mediated suppression of cell growth, invasion and metastasis

1 reference

12 December 2020

Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence

1 reference

12 December 2020

Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA

1 reference

12 December 2020

MicroRNAs in cancer - from research to therapy

1 reference

12 December 2020

MicroRNA-107, an oncogene microRNA that regulates tumour invasion and metastasis by targeting DICER1 in gastric cancer

1 reference

12 December 2020

Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer

1 reference

12 December 2020

Nonviral in vivo delivery of therapeutic small interfering RNAs

1 reference

12 December 2020

Metastasis mechanisms

1 reference

12 December 2020

10.1007/S00109-010-0716-0

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21234533